NUCLEOLIN and cancer: Altogether, taking the fact that nucleolin is both expressed in CSC and non-SCC, and in other cell compartments as the tumor vasculature, one might envision nucleolin as a pan-target, that when explored to promote the delivery of the adequate drugs, may enable the debulk of tumors while simultaneously providing a mean to precisely tackle CSC, the embodiment of stemness in cancer.